From TD web broker Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that its European subsidiary, Theratechnologies International Limited, has appointed Mr. Conor Walshe as its General Manager.
Mr. Walshe will be based in Dublin, Ireland, where Theratechnologies European head office will be established.
"We could not be happier with the hiring of Conor whom we will be able to rely on for his in-depth expertise, knowledge and acumen as we establish our presence in Europe. The potential launch of Trogarzo in Europe requires the flawless implementation of an infrastructure that will be able to deliver on many key success factors including distribution, reimbursement, sales, marketing and relationships with key stakeholders," said Luc Tanguay, President and Chief Executive Officer, Theratechnologies Inc.
"Conor was selected as General Manager, after a thorough European search, based on his demonstrated capacity and ability to deliver on those critical issues for Theratechnologies in Europe. As soon as he begins his mandate, he will be working with our contract sales organization on building the right field infrastructure in key European countries and he will complete the hiring of key internal strategic positions," concluded Mr. Tanguay.
Prior to joining our European subsidiary, Mr. Walshe was General Manager and Vice President, Operations and Commercial, at Aralez Plc. Prior to Aralez Plc, Mr. Walshe spent more than 15 years in the pharmaceutical industry including at Perrigo Plc, Elan Plc and Venn Life Sciences where he was called upon to serve, among others, as CFO, Senior Vice President Commercial and Financial Operations and in product management.
Mr. Walshe is a Chartered Accountant. He holds a Bachelor of Commerce and a Master in Business Studies from the University College in Dublin. He also obtained a diploma in IFRS from the Institute of Chartered Accountants and in Advanced International Corporate Finance from INSEAD.